(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
33.62% SEK 0.310
Live Chart Being Loaded With Signals
Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain...
Stats | |
---|---|
Volumen de hoy | 1.09M |
Volumen promedio | 159 976 |
Capitalización de mercado | 9.83M |
EPS | SEK-0.222 ( 2023-09-30 ) |
Próxima fecha de ganancias | ( SEK0 ) 2024-05-31 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.310 |
ATR14 | SEK0.0140 (4.52%) |
Stayble Therapeutics AB Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Stayble Therapeutics AB Finanzas
Annual | 2023 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-0.920 |
FY | 2023 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-0.920 |
FY | 2022 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-1.700 |
FY | 2021 |
Ingresos: | SEK0.00 |
Beneficio Bruto: | SEK0.00 (0.00 %) |
EPS: | SEK-0.873 |
Financial Reports:
No articles found.
Stayble Therapeutics AB
Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico